): The continuing goal of this training program in Tumor Immunology and Cancer Cell/Molecular Biology is to educate and train scientists for research and education in academics, government and industry. The training program is based in the Department of Microbiology and Immunology but also includes faculty from the Departments of Pathology, Surgery, and Biochemistry. The program of study is based on a strong didactic base, and the availability of exciting well- funded research programs administered by faculty with experience in training both pre-doctoral and post-doctoral fellows. A major strength of this program is the strong interactive training environment which exists with regard to both teaching and research. This has resulted in a high degree of collaborative research both among the program faculty and trainees and with scientists outside the institution. Research training in which the eighteen participating faculty are currently involved encompasses the areas of tumor immunology, regulation of the immune response, neuroimmunology, molecular immunology, gene regulation and tumor biology. The program emphasizes multidisciplinary research training based on a foundation of formal instruction in immunology, molecular biology, biochemistry, virology, biopathology/oncology and supporting fields. This program, which is at the pre-doctoral and post-doctoral level, has contributed substantially to the quality and unity of the total program of training and research in tumor immunology and cancer cell/ molecular biology at the University of Kentucky, and has resulted in focusing additional University support in these areas. In addition to the faculty participating in this training program, numerous other immunologists and faculty, in related and supportive areas, participate actively in our seminar programs and teaching programs. During the past funding period there has been a steady growth in program quality and breadth by the addition of new faculty and the productivity and recognition of existing faculty. Additional growth and development will occur over the next five years as several newly recruited junior faculty join the program as members and as the Cancer Center expands under the new director. The growth in faculty has been accomplished by a comparable growth in training. In summary, this has been a successful program that has emphasized multidisciplinary training, and has since 1985 trained 20 pre-doctoral and 10 post-doctoral students whose careers have developed in an exemplary manner.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009509-15
Application #
2894399
Study Section
Special Emphasis Panel (SRC (B1))
Program Officer
Gorelic, Lester S
Project Start
1985-07-01
Project End
2001-06-30
Budget Start
1999-07-01
Budget End
2001-06-30
Support Year
15
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Kentucky
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
832127323
City
Lexington
State
KY
Country
United States
Zip Code
40506
Butler, James E; Moore, Mikel B; Presnell, Steven R et al. (2009) Proteasome regulation of ULBP1 transcription. J Immunol 182:6600-9
Calfee-Mason, Karen G; Lee, Eun Y; Spear, Brett T et al. (2008) Role of the p50 subunit of NF-kappaB in vitamin E-induced changes in mice treated with the peroxisome proliferator, ciprofibrate. Food Chem Toxicol 46:2062-73
Schneeman, Tracey A; Bruno, Maria E C; Schjerven, Hilde et al. (2005) Regulation of the polymeric Ig receptor by signaling through TLRs 3 and 4: linking innate and adaptive immune responses. J Immunol 175:376-84
Bryson, J Scott; Zhang, Lining; Goes, Sarah W et al. (2004) CD4+ T cells mediate murine syngeneic graft-versus-host disease-associated colitis. J Immunol 172:679-87
Calfee-Mason, Karen G; Spear, Brett T; Glauert, Howard P (2004) Effects of vitamin E on the NF-kappaB pathway in rats treated with the peroxisome proliferator, ciprofibrate. Toxicol Appl Pharmacol 199:1-9
Fernandez, Stefan; Knopf, Melissa A; Shankar, Gopi et al. (2003) Calcitonin gene-related peptide indirectly inhibits IL-7 responses in pre-B cells by induction of IL-6 and TNF-alpha in bone marrow. Cell Immunol 226:67-77
Flanagan, D M; Jennings, C D; Goes, S W et al. (2002) Nitric oxide participates in the intestinal pathology associated with murine syngeneic graft-versus-host disease. J Leukoc Biol 72:762-8
Calfee-Mason, Karen G; Spear, Brett T; Glauert, Howard P (2002) Vitamin E inhibits hepatic NF-kappaB activation in rats administered the hepatic tumor promoter, phenobarbital. J Nutr 132:3178-85
Hempen, Paula M; Phillips, Kimberly M; Conway, Pamela S et al. (2002) Transcriptional regulation of the human polymeric Ig receptor gene: analysis of basal promoter elements. J Immunol 169:1912-21
McGillis, Joseph P; Miller, Christopher N; Schneider, David B et al. (2002) Calcitonin gene-related peptide induces AP-1 activity by a PKA and c-fos-dependent mechanism in pre-B cells. J Neuroimmunol 123:83-90

Showing the most recent 10 out of 36 publications